Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Recruiting 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2Head & Neck 1Gastrointestinal 1Dermatologic 1CNS 1

Conditions

Neoplasm Metastasis 3Carcinoma, Non-Small-Cell Lung 2Urothelial Cancer 1Thyroid Neoplasms 1Pancreatic Neoplasms 1Neoplasms by Site 1Neoplasms 1Melanoma 1Lung Neoplasms 1Glioma 1Gastrointestinal Stromal Tumors 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma 1Advanced Malignancies 1

Interventions

pembrolizumab 55Carboplatin 55Pemetrexed 47Cisplatin 37Paclitaxel 21Nivolumab 20Docetaxel 19durvalumab 18osimertinib 14Gemcitabine 14Cetuximab 14130-nm albumin-bound paclitaxel 14atezolizumab 12Specimen Handling 12Magnetic Resonance Spectroscopy 12amivantamab 10Radiotherapy 8lazertinib 7Taxes 7Radiosurgery 7alectinib 6Ramucirumab 6Observation 6Ipilimumab 6Bevacizumab 6cemiplimab 5Leucovorin 5Fluorouracil 5zimberelimab 4entrectinib 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Carcinoma, Non-Small-Cell Lung × Midazolam × 30 days × Clear all
NCT06835569 2026-06-10

A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations

Alterome Therapeutics, Inc.

Phase 1 Recruiting
448 enrolled
GastrointestinalThoracic

Carcinoma, Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Lung Neoplasms, Neoplasm Metastasis, Neoplasms, Neoplasms by Site, Pancreatic Neoplasms, Colorectal Neoplasms

NCT05355701 2026-06-05

A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.

Pfizer

Phase 1 Recruiting
267 enrolled
CNSDermatologicHead & NeckThoracic

Carcinoma, Non-Small-Cell Lung, Glioma, Melanoma, Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡